Vadodara, India

Ashish Anilrao Dubewar

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Ashish Anilrao Dubewar

Introduction

Ashish Anilrao Dubewar is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work aims to enhance patient care by simplifying the administration of medications.

Latest Patents

Ashish holds a patent for a perfusion dosage form. This invention relates to a method that enables hospitals or clinics to administer a dose of a drug to patients without the need for manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling, or compounding before intravenous administration. The perfusion system he developed comprises different sets of perfusion containers, each containing a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug. This system allows for direct intravenous administration of a desired dose of the drug, ensuring that the delivered dose is equal to or within ±5% of the calculated dose. He has 1 patent to his name.

Career Highlights

Ashish is currently employed at Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role involves research and development, focusing on innovative solutions that improve drug delivery and patient outcomes.

Collaborations

He has collaborated with notable colleagues such as Samarth Kumar and Prashant Kane, contributing to various projects aimed at advancing pharmaceutical technologies.

Conclusion

Ashish Anilrao Dubewar's innovative work in drug delivery systems exemplifies the impact of inventions on healthcare. His contributions are paving the way for more efficient and patient-friendly medical practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…